|
joyjac ★ Philippines, 2011-07-05 09:53 (5461 d 07:41 ago) Posting: # 7207 Views: 6,251 |
|
|
Hi colleagues, The EMEA guideline states that it is acceptable to use a two-stage approach when attempting to demonstrate bioequivalence. Can anyone enlighten me on this kind of study design, steps to be taken, stopping criteria or can we automatically switch to stage 2 if the BE fails at stage 1? Thanks and regards. Edit: Category changed. [Helmut] |
|
Helmut ★★★ ![]() Vienna, Austria, 2011-07-05 21:38 (5460 d 19:57 ago) @ joyjac Posting: # 7211 Views: 5,144 |
|
|
Dear Joy, EMA does not specify a particular method. One of them (Potvin et al. 2008) we have discussed numerous times in the forum. See e.g. this post. — Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![]() Helmut Schütz ![]() The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |

![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
![[image]](https://static.bebac.at/img/CC by.png)
